Cardiac Biomarkers in Acute Myocardial Infarction

Mahmoud Allahham, Mohita Singh, Hani Jneid

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Scopus citations


Acute myocardial infarction (MI) is defined by the presence of myocardial necrosis in the clinical setting of acute myocardial ischemia as supported by history, physical exam, electrocardiograpic (ECG) findings and biochemical markers of myocardial necrosis. Given the wide array of biomarkers available with varying degrees of sensitivity and specificity, this chapter aims to provide an overview of the role of contemporary and emerging biomarkers in patients with acute coronary syndrome (ACS) and acute myocardial infarction (AMI). We focus particularly on patients with non-ST myocardial infarction (NSTEMI), given this syndrome will depend to a larger extent on risk stratification and diagnostic assays to dictate in-hospital treatment. This chapter will first review the third universal definition of MI then summarize the recommendations of various societies on the utilization of cardiac biomarkers in the diagnosis and management of AMI. We aim to compare and contrast these recommendations and provide commentary on the issues and controversies arising from differences between them.

Original languageEnglish (US)
Title of host publicationBiomarkers in Cardiovascular Disease
Number of pages6
ISBN (Electronic)9780323548359
StatePublished - Jan 1 2018
Externally publishedYes


  • ACS
  • BNP
  • Biomarker
  • CK-MB
  • Cardiac
  • Myocardial infraction
  • Myoglobin
  • Troponin

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Cardiac Biomarkers in Acute Myocardial Infarction'. Together they form a unique fingerprint.

Cite this